Shanghai Brilliance Cancer Pharmaceutical

Shanghai Brilliance Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Shanghai, China, primarily focused on the development, manufacturing, and commercialization of oncology treatments. As a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), the company operates as a key production base for anti-tumor drugs within the group. Its portfolio includes a wide range of generic and innovative small molecule therapies targeting various solid tumors and hematological malignancies. The company maintains high-standard manufacturing facilities that comply with Chinese GMP requirements and serves both domestic and international markets. Shanghai Brilliance is recognized for its established presence in the Chinese oncology market and its role in providing affordable cancer medications.